AXIM Biotechnologies, Inc.
AXIM · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3 | $7 | $0 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $3 | $8 | $1 | $16 |
| Property Plant & Equip (Net) | $218 | $227 | $237 | $271 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $3,003 | $3,102 | $3,201 | $3,299 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $9 | $9 | $9 |
| Total NC Assets | $3,221 | $3,338 | $3,447 | $3,579 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,224 | $3,346 | $3,447 | $3,596 |
| Liabilities | – | – | – | – |
| Payables | $1,796 | $1,928 | $1,786 | $1,756 |
| Short-Term Debt | $102 | $77 | $77 | $74 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $233 | $233 |
| Other Curr. Liab. | $4,309 | $4,672 | $4,666 | $4,622 |
| Total Curr. Liab. | $6,206 | $6,677 | $6,762 | $6,684 |
| LT Debt | $7,444 | $7,307 | $6,563 | $6,937 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $541 | $0 |
| Total NC Liab. | $7,444 | $7,307 | $7,104 | $6,937 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $102 | $141 | $63 | $90 |
| Total Liabilities | $13,650 | $13,983 | $13,867 | $13,621 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $36 | $33 | $32 | $30 |
| Retained Earnings | -$75,793 | -$75,932 | -$75,697 | -$75,281 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $65,332 | $65,261 | $65,246 | $65,225 |
| Total Equity | -$10,426 | -$10,637 | -$10,420 | -$10,026 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,224 | $3,346 | $3,447 | $3,596 |
| Net Debt | $7,543 | $7,377 | $6,640 | $7,010 |